InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Hunt Hazel, Directeur Scientifique. Officer active across 2 companies, notably Corcept Therapeutics INC. In total, 4 filings have been published. The latest transaction was filed on 26 January 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€117,47540,000 shares@ €2.93690.0032% mcap49.0% of flow
Common Stock
SEC:0000899243-22-003573·
€117,47540,000 shares@ €2.93690.0019% mcap49.0% of flow
Common Stock
SEC:0000899243-22-003573:0·
€122,11350,000 shares@ €2.44230.0033% mcap51.0% of flow
Common Stock
SEC:0000899243-21-028678·
€122,11350,000 shares@ €2.44230.0020% mcap51.0% of flow
Common Stock
SEC:0000899243-21-028678:0·
4 of 4 declarations
About Hunt Hazel
Hazel Hunt is the Chief Scientific Officer at Corcept Therapeutics Inc. In this role, she is responsible for leading research and the development of new treatments. Her scientific expertise is essential for innovation within the company.
